PAUL V. MAIER - 09 Jun 2022 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Russell Kern, Attorney-in-Fact
Issuer symbol
ISCO
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 17:01:01 UTC
Previous filing
28 Feb 2022
Next filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +139,264 $0.000000 139,264 09 Jun 2022 Common Stock 139,264 $0.4740 Direct F1
transaction ISCO Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Jun 2022 Common Stock 30,000 $0.4740 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/09/2022.
F2 Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) 06/09/2023 or (ii) the date of the 2023 Annual Meeting of Stockholders.

Remarks:

EX-24 attached